If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
TRULICITY® (dulaglutide): Route of Administration
Trulicity (dulaglutide) should be injected subcutaneously in the abdomen, thigh, or upper arm.
Trulicity® (dulaglutide) should be injected subcutaneously in the abdomen, thigh, or upper arm. It must not be injected intravenously or intramuscularly (Trulicity Package Insert, 2017).
Enclosed Prescribing Information
TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly
The published reference below is available upon request by contacting 1-800-LillyRx.
Reference
Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2017.
Date of Last Review: January 17, 2017
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 8am - 7pm ET
